文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

血肿扩大特征在深部和脑叶脑出血中的表现。

Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage.

机构信息

Department of Neurology, University of Erlangen-Nürnberg, Schwabachanlage 6, Erlangen, 91054, Germany.

Department of Neuroradiology, University of Erlangen-Nürnberg, Schwabachanlage 6, Erlangen, 91054, Germany.

出版信息

Ann Clin Transl Neurol. 2020 Mar;7(3):363-374. doi: 10.1002/acn3.51001. Epub 2020 Mar 4.


DOI:10.1002/acn3.51001
PMID:32133793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7086015/
Abstract

OBJECTIVE: Hematoma enlargement (HE) is associated with clinical outcomes after supratentorial intracerebral hemorrhage (ICH). This study evaluates whether HE characteristics and association with functional outcome differ in deep versus lobar ICH. METHODS: Pooled analysis of individual patient data between January 2006 and December 2015 from a German-wide cohort study (RETRACE, I + II) investigating ICH related to oral anticoagulants (OAC) at 22 participating centers, and from one single-center registry (UKER-ICH) investigating non-OAC-ICH patients. Altogether, 1954 supratentorial ICH patients were eligible for outcome analyses, which were separately conducted or controlled for OAC, that is, vitamin-K-antagonists (VKA, n = 1186) and non-vitamin-K-antagonist-oral-anticoagulants (NOAC, n = 107). Confounding was addressed using propensity score matching, cox regression modeling and multivariate modeling. Main outcomes were occurrence, extent, and timing of HE (>33%/>6 mL) and its association with 3-month functional outcome. RESULTS: Occurrence of HE was not different after deep versus lobar ICH in patients with non-OAC-ICH (39/356 [11.0%] vs. 36/305 [11.8%], P = 0.73), VKA-ICH (249/681 [36.6%] vs. 183/505 [36.2%], P = 0.91), and NOAC-ICH (21/69 [30.4%] vs. 12/38 [31.6%], P = 0.90). HE extent did not differ after non-OAC-ICH (deep:+59% [40-122] vs. lobar:+74% [37-124], P = 0.65), but both patients with VKA-ICH and NOAC-ICH showed greater HE extent after deep ICH [VKA-ICH, deep: +94% [54-199] vs. lobar: +56% [35-116], P < 0.001; NOAC-ICH, deep: +74% [56-123] vs. lobar: +40% [21-49], P = 0.001). Deep compared to lobar ICH patients had higher HE hazard during first 13.5 h after onset (Hazard ratio [HR]: 1.85 [1.03-3.31], P = 0.04), followed by lower hazard (13.5-26.5 h, HR: 0.46 [0.23-0.89], P = 0.02), and equal hazard thereafter (HR: 0.96 [0.56-1.65], P = 0.89). Odds ratio for unfavorable outcome was higher after HE in deep (4.31 [2.71-6.86], P < 0.001) versus lobar ICH (2.82 [1.71-4.66], P < 0.001), and only significant after small-medium (1st volume-quarter, deep: 3.09 [1.52-6.29], P < 0.01; lobar: 3.86 [1.35-11.04], P = 0.01) as opposed to large-sized ICH (4th volume-quarter, deep: 1.09 [0.13-9.20], P = 0.94; lobar: 2.24 [0.72-7.04], P = 0.17). INTERPRETATION: HE occurrence does not differ among deep and lobar ICH. However, compared to lobar ICH, HE after deep ICH is of greater extent in OAC-ICH, occurs earlier and may be of greater clinical relevance. Overall, clinical significance is more apparent after small-medium compared to large-sized bleedings.

摘要

目的:血肿扩大(HE)与幕上脑出血(ICH)后的临床结局相关。本研究评估深部和脑叶 ICH 之间 HE 特征及其与功能结局的相关性是否存在差异。

方法:对 22 个参与中心调查与口服抗凝剂(OAC)相关的 ICH 的德国范围队列研究(RETRACE,I+II)和一个调查非 OAC-ICH 患者的单中心登记处(UKER-ICH)中,2006 年 1 月至 2015 年 12 月期间的个体患者数据进行汇总分析。共有 1954 例幕上 ICH 患者有资格进行结局分析,分别针对 OAC(VKA,n=1186;NOAC,n=107)和非 OAC 进行了分析。混杂因素通过倾向评分匹配、Cox 回归建模和多变量建模来解决。主要结局是 HE(>33%/ >6 mL)的发生、程度和时间及其与 3 个月功能结局的相关性。

结果:在非 OAC-ICH 患者中,深部与脑叶 ICH 后 HE 的发生率无差异(39/356 [11.0%] vs. 36/305 [11.8%],P=0.73)、VKA-ICH(249/681 [36.6%] vs. 183/505 [36.2%],P=0.91)和 NOAC-ICH(21/69 [30.4%] vs. 12/38 [31.6%],P=0.90)。非 OAC-ICH 后 HE 程度无差异(深部:+59%[40-122] vs. 脑叶:+74%[37-124],P=0.65),但 VKA-ICH 和 NOAC-ICH 患者深部 ICH 后 HE 程度更大[VKA-ICH,深部:+94%[54-199] vs. 脑叶:+56%[35-116],P<0.001;NOAC-ICH,深部:+74%[56-123] vs. 脑叶:+40%[21-49],P=0.001]。与脑叶 ICH 患者相比,深部 ICH 患者在发病后前 13.5 小时内 HE 的发生风险更高(风险比[HR]:1.85[1.03-3.31],P=0.04),随后风险降低(13.5-26.5 小时,HR:0.46[0.23-0.89],P=0.02),此后风险相等(HR:0.96[0.56-1.65],P=0.89)。深部 ICH 患者 HE 后不良结局的比值比高于脑叶 ICH(4.31[2.71-6.86],P<0.001),仅在中小体积 ICH (第 1 体积四分之一,深部:3.09[1.52-6.29],P<0.01;脑叶:3.86[1.35-11.04],P=0.01)中具有统计学意义,而在大体积 ICH (第 4 体积四分之一,深部:1.09[0.13-9.20],P=0.94;脑叶:2.24[0.72-7.04],P=0.17)中无统计学意义。

解释:深部和脑叶 ICH 之间 HE 的发生没有差异。然而,与脑叶 ICH 相比,OAC-ICH 后深部 ICH 的 HE 程度更大,发生更早,可能具有更大的临床相关性。总体而言,与大体积出血相比,中小体积出血的临床意义更为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/56f1a3dcdbff/ACN3-7-363-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/6a289d0695e8/ACN3-7-363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/e46da55fee79/ACN3-7-363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/f415c7625e7a/ACN3-7-363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/113633fa312e/ACN3-7-363-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/56f1a3dcdbff/ACN3-7-363-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/6a289d0695e8/ACN3-7-363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/e46da55fee79/ACN3-7-363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/f415c7625e7a/ACN3-7-363-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/113633fa312e/ACN3-7-363-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/7086015/56f1a3dcdbff/ACN3-7-363-g005.jpg

相似文献

[1]
Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage.

Ann Clin Transl Neurol. 2020-3

[2]
Blood Pressure and Anticoagulation Reversal Management during Off-Hours in Oral Anticoagulation-Associated Intracerebral Hemorrhage.

Cerebrovasc Dis. 2020-4-22

[3]
Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.

Stroke. 2019-5-16

[4]
Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use.

J Neurol. 2019-9-20

[5]
Outcome of intracerebral hemorrhage associated with different oral anticoagulants.

Neurology. 2017-5-2

[6]
Age-dependent clinical outcomes in primary versus oral anticoagulation-related intracerebral hemorrhage.

Int J Stroke. 2021-1

[7]
Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage.

Ann Neurol. 2018-10-25

[8]
Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study.

Stroke. 2021-1

[9]
Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage.

Neurology. 2020-12-15

[10]
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.

J Neurol Neurosurg Psychiatry. 2017-10-13

引用本文的文献

[1]
[In-hospital management of intracerebral hemorrhage].

Med Klin Intensivmed Notfmed. 2025-3

[2]
Association of non-contrast CT markers with long-term functional outcome in deep intracerebral hemorrhage.

Front Neurol. 2024-1-11

[3]
Hematoma expansion in intracerebral hemorrhage - the right target?

Neurol Res Pract. 2023-7-27

[4]
Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.

Brain Commun. 2023-5-19

[5]
Quantitative hematoma heterogeneity associated with hematoma growth in patients with early intracerebral hemorrhage.

Front Neurol. 2022-10-21

[6]
A non-contrast computed tomography-based radiomics nomogram for the prediction of hematoma expansion in patients with deep ganglionic intracerebral hemorrhage.

Front Neurol. 2022-10-11

[7]
Characteristics of Early Presenters after Intracerebral Hemorrhage.

J Stroke. 2022-9

[8]
Cerebral Amyloid Angiopathy and the Risk of Hematoma Expansion.

Ann Neurol. 2022-12

[9]
Patient factors associated with receiving reversal therapy in oral anticoagulant-related intracerebral hemorrhage.

Acta Neurol Scand. 2022-11

[10]
Early Prediction of Cerebral Computed Tomography under Intelligent Segmentation Algorithm Combined with Serological Indexes for Hematoma Enlargement after Intracerebral Hemorrhage.

Comput Math Methods Med. 2022

本文引用的文献

[1]
Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage.

JAMA. 2019-10-8

[2]
Hematoma Expansion in ICH: Targeting Epidemiology or Biology?

Neurocrit Care. 2019-8

[3]
Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.

Stroke. 2019-5-16

[4]
Association of Intensive Blood Pressure Reduction With Risk of Hematoma Expansion in Patients With Deep Intracerebral Hemorrhage.

JAMA Neurol. 2019-8-1

[5]
Location of intracerebral haemorrhage predicts haematoma expansion.

Eur Stroke J. 2017-9

[6]
Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage.

J Neurol Neurosurg Psychiatry. 2019-4-16

[7]
Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage.

Neurocrit Care. 2019-8

[8]
Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.

Stroke. 2018-11

[9]
Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations.

J Neurol. 2018-8-20

[10]
Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

Lancet Neurol. 2018-8-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索